Billionaire businessman Jimnah Mbaru in a past address. Photo: Jimnah Mbaru. Source: Twitter
The matter was being arbitrated before Milimani Children’s Court Principal Magistrate Jackie Kibosia, with the woman seeking orders to have Mbaru undergo paternity test to ascertain whether or not he is the father of the four-year-old at the centre of the suit.
The lady moved to court seeking Mbaru to be compelled to take paternity responsibilities after alleged negligence. During the initial proceedings of the matter on Tuesday, October 18, the businessman applied for the media to be gagged from covering the matter.
However, the woman’s lawyer Lempaa Soyinka opposed the application saying the court should take notice that young mothers are disappearing when they sue influential people for child maintenance. He said the security of the child is tied to the security of the mother and that can only be realised when the matter remained in the public.
The court however, considered Mbaru's request and directed journalists who were following the proceedings virtually to log out. KSh 4.4 million The 24-year-old mother is seeking KShs 4.4 million per year for child support.
The young mother alleged that the businessman donated his parental responsibility to one Erick Murimi Kaburu through a power of attorney, thereby, treating the minor as a ‘property of chattel goods.’ “The said Memorandum of Understanding dated September 10, the “putative father” was required to pay KShs 50,000 per month, an amount has not been remitted for the maintenance of the minor,” she claims in court documents.
In the suit papers, among other expenses, she is seeking KShs 320,000 monthly and 600,000 per year for the minor who is enrolled at Kitengela International School located in Kajiado county. In the monthly expenses, she is seeking KShs 50,000 for food, KShs 50,000 for medical expenses, KShs 50,000 for clothes, KShs 100,000 for shopping, miscellaneous expenses KShs 20,000 and house help KShs 50,000. Source: Tuko
The Ethics and Anti-Corruption Commissionhas raised concern over the increased number of alleged falsification and forgery of academic certificates in the country.
The commission has written a circular which is addressed to all University Vice Chancellors, Chairpersons of University Councils, Commission for University Education and the Kenya National Examinations Council.
“The most prevalent and rampant irregularities that have been noted include, alteration of the grades in the Kenya Certificate of Secondary Education so as to gain admission into graduate and postgraduate programmes in universities and alteration of names on genuine certificates to enable the person altering to impersonate the ones named therein so as to either apply for admission to learning institutions or seek employment,” the statement read.
The anti-graft body also listed “Cases of missing admission records or documents and other relevant information from a student’s file or profile thereby making it difficult or impossible for law enforcement agencies to verify the bona fides of a person when investigating the foregoing allegations,” as part of the irregularities.
EACC has said that the increased cases are a threat to Kenya’s education system and if they remain unchecked it will compromise the value of the public service.
“It is therefore important that concerted efforts that bring on board all concerned stakeholders be embarked upon, to seek a lasting solution on how these vices can be curbed,” the commission said.
EACC has urged major education stakeholders to establish and operationalize mechanisms to ensure the authenticity of academic records that are issued to graduates and post-graduates. By Elaine Kirui, The Standard
The monkeypox virus (MPXV), which was first isolated in 1958, is a double-stranded DNA (dsDNA) virus. It was recognized as a zoonotic disease when the first human case was detected in the Democratic Republic of the Congo in 1970. There is currently a global concern over MPXV due to its wider transmission from Central and West Africa.
Rapid, ultrasensitive, and specific detection is essential to curb this virus's spread. In a new study posted to the medRxiv* preprint server, researchers in China developed an MPXV assay combining clustered regularly interspaced short palindromic repeats and CRISPR-associated protein (CRISPR/Cas) and recombinase-aided amplification (RAA) for the first time. The assay exhibited high selectivity and could distinguish between MPXV and other orthopoxviruses.
Currently, MPXV testing uses methods such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and loop-mediated isothermal amplification (LAMP). PCR is the gold standard and is accurate and sensitive but challenging to deploy in low-resource areas. ELISA could provide false positive results for recent or remote vaccination, and LAMP’s disadvantages are related to a complicated primer design, poor quantitative performance, etc. Rapid, ultrasensitive, and low-cost methods facilitating on-site and facile MPXV detection have remained absent.
About the Study
CRISPR/Cas was first discovered in the adaptive immune system of prokaryotes. CRISPR/Cas12a system integrates signal transduction, and biorecognition has been used to detect several viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has many advantages related to mild conditions, high sensitivity, operational ease, and powerful signal amplification.
To date, critical issues related to using CRISPR technology in MPXV detection, such as probe screening, analytical performance, pre-amplification, and point-of-care testing (POCT), have not been reported. Therefore, the current study proposed a rapid and ultrasensitive assay combining recombinase-aided amplification (RAA) and CRISPR/Cas12a, i.e., the RAA-Cas12a-MPXV assay, for the first time. The principle comprised three steps: RAA amplification, CRISPR/Cas12a cleavage, and signal output.
In the first step, RAA selecting the DNA template produced a large number of amplicons. This augmented the sensitivity of the assay significantly. In the second step, the trans-cleavage activity of Cas12a was activated, which resulted in numerous ssDNA reporters being cleaved. The last step produced two different signal output modes: fluorescence assay for FQ reporters and lateral flow strip, which improved the usability and suitability of the RAA-Cas12a-MPXV assay.
Fluorescence results with or without DNA templates and the RAA product were compared to evaluate the feasibility of the assay. The no DNA group was the control, which showed no significant fluorescence change. This indicated that, in the absence of DNA templates, no RAA amplicon was generated for it to be recognized by subsequent CRISPR/Cas12a.
To ensure greater selectivity and sensitivity, three pairs of primers that bound to various sites of the MPXV-specific F3L gene were designed. To screen the optimal primers for future experiments, the RAA-Cas12a-MPXV fluorescence assay and the agarose gel electrophoresis (AGE) were performed. The third pair (F2+R2) achieved the brightest specific amplification band.
Many important experimental conditions related to the CRISPR/Cas12a system and the RAA-Cas12a-MPXV assay were optimized, with RAA's temperature and reaction time being the first. Next, the CRISPR/Cas12a system with crRNA2 was optimized.
The RAA-Cas12a-MPXV fluorescence assay was deemed to be easy to operate and amenable to be used for rapid testing. Compared to the PCR-Cas12a-MPXV fluorescence assay, the RAA-Cas12a-MPXV fluorescence assay revealed outstanding sensitivity with a 1000-fold lower limit of detection (LOD).
The selectivity of the RAA-Cas12a-MPXV fluorescence assay was determined by comparing the degree of fluorescence produced by MPXV with other viruses, such as variola virus (VARV), cowpox virus (CPXV), severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), Toxoplasma Gondii virus (TOXV), and African swine fever virus (ASFV). Both naked eye observation and fluorescence values indicated that only MPXV induced enhanced fluorescence, while other viruses did not.
The FAM-Biotin reporter (FB-reporter) reporter was designed as a substitute for the FQ reporter of the fluorescence assay, and subsequently, the RAA-Cas12a-MPXV lateral flow strip assay was established for POCT. The addition of a reaction solution containing intact FB reporters cracked FAMs and biotin in the sample pads caused rapid binding of the anti-FAM antibody/AuNP complexes with isolated FAMs and FB reporters as the sample migrated forward. Finally, streptavidin, immobilized at the control band, captured cracked biotins and the FB reporter/anti-FAM antibody/AuNP complexes.
Initially, the control band appeared red due to the aggregation of AuNPs. Subsequently, the rest of the isolated FAM/anti-FAM antibody/AuNP complexes traveled towards the test band and reacted with FAM antibodies appearing red. Finally, amplicons activated Cas12a to cleave all FB reporters. The change of color only remained at the test band.
In a nutshell, when the color change was observed only in the test band or both the control and the test band, it was considered a positive result. In contrast, if the color change was only found at the control band, it indicated a negative result, i.e., the absence of DNA templates led to no amplicons for Cas12a activation.
A vital advantage of the RAA-Cas12a-MPXV assay is that it can be conducted at a mild temperature compared to conventional processes. Importantly, this assay was a powerful MPXV diagnosis method with superior selectivity, sensitivity, and portability. By Dr. Priyom Bose, Ph.D.Oct 18 2022 Reviewed by Danielle Ellis, B.Sc. Source Libyan Cloud Agency
Informer East Africa is a UK based diaspora Newspaper. It is a unique platform connecting East Africans at home and abroad through news dissemination. It is a forum to learn together, grow together and get entertained at the same time.
To advertise events or products, get in touch by info [at] informereastafrica [dot] com or call +447957636854. If you have an issue or a story, get in touch with the editor through editor[at] informereastafrica [dot] com or call +447886544135.
We also accept donations from our supporters. Please click on "donate". Your donations will go along way in supporting the newspaper.